SCHEMBL13897841

SCHEMBL13897841

COC(=O)Nc1ccc(Nc2ncc(Br)c(NCCc3c[nH]cn3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.45
▸ NTRK2 Q16620 1/20 0.45
▸ STK17B O94768 1/20 0.44
▸ STK17A Q9UEE5 1/20 0.44
▸ TBK1 Q9UHD2 3/20 0.43
▸ AURKA O14965 1/20 0.43
▸ MARK3 P27448 1/20 0.43
▸ MARK4 Q96L34 1/20 0.43
▸ CA2 P00918 4/20 0.42
▸ CDK1 P06493 11/20 0.41
▸ KDR P35968 9/20 0.41
▸ CDK2 P24941 10/20 0.41
▸ CCNB1 P14635 3/20 0.41
▸ CCNE1 P24864 3/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ CDK4 P11802 2/20 0.41
▸ CDK7 P50613 2/20 0.41
▸ CDK9 P50750 2/20 0.41
▸ CCNT1 O60563 1/20 0.41
▸ CCND1 P24385 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3865639 0.91 TBK1 (0.54) STK17ATBK1AURKAMARK3MARK4
SCHEMBL3865685 0.90 CHEK1 (0.48) CHEK1NTRK2STK17BSTK17ATBK1
SCHEMBL13897608 0.89 STK17B (0.47) CHEK1NTRK2STK17BSTK17ATBK1
SCHEMBL13901411 0.89 SYK (0.37) CHEK1NTRK2STK17AAURKACDK2
SCHEMBL13648566 0.87 CHEK1 (0.48) CHEK1NTRK2STK17BSTK17ATBK1
SCHEMBL13897715 0.87 TBK1 (0.47) CHEK1NTRK2STK17BSTK17ATBK1
SCHEMBL13897646 0.87 STK17B (0.42) CHEK1NTRK2STK17BSTK17ATBK1
SCHEMBL13897812 0.86 GSK3B (0.58) CHEK1NTRK2STK17BSTK17ATBK1
SCHEMBL13897823 0.86 STK17B (0.42) STK17BSTK17ATBK1AURKAMARK3
SCHEMBL6542486 0.85 IGF1R (0.52) CHEK1NTRK2STK17BSTK17ATBK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 — — US disclosed
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 — — US disclosed
Send feedback